Trial Profile
A multicentre, open study assessing joint disorders Under ARIMIDEX [anastrozole] (1mg/Day) as adjuvant treatment in post menopausal women with early breast cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2012
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 05 Apr 2012 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 05 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.